Cargando…
Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908950/ https://www.ncbi.nlm.nih.gov/pubmed/31866853 http://dx.doi.org/10.3389/fnagi.2019.00331 |
_version_ | 1783478848543784960 |
---|---|
author | Lucio, Marianna Willkommen, Desiree Schroeter, Michael Sigaroudi, Ali Schmitt-Kopplin, Philippe Michalke, Bernhard |
author_facet | Lucio, Marianna Willkommen, Desiree Schroeter, Michael Sigaroudi, Ali Schmitt-Kopplin, Philippe Michalke, Bernhard |
author_sort | Lucio, Marianna |
collection | PubMed |
description | Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites and metallomic data, in this research, we combined a control study measured using two different platforms. For the different data sources, we applied a Block Sparse Partial Least Square Discriminant Analysis (Block-sPLS-DA) model that allows for proving their relation, which in turn uncovers alternative influencing factors that remain hidden otherwise. We found two groups of variables that trace a strong relationship between metallomic and metabolomic parameters for disease development. The results confirmed that the redox active metals iron (Fe) and copper (Cu) together with fatty acids are the major influencing factors for the PD. Additionally, the metabolic waste product p-cresol sulfate and the trace element nickel (Ni) showed up as potentially important factors in PD. In summary, the data integration of different types of measurements emphasized the results of both stand-alone measurements providing a new comprehensive set of information and interactions, on PD disease, between different variables sources. |
format | Online Article Text |
id | pubmed-6908950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69089502019-12-20 Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease Lucio, Marianna Willkommen, Desiree Schroeter, Michael Sigaroudi, Ali Schmitt-Kopplin, Philippe Michalke, Bernhard Front Aging Neurosci Neuroscience Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites and metallomic data, in this research, we combined a control study measured using two different platforms. For the different data sources, we applied a Block Sparse Partial Least Square Discriminant Analysis (Block-sPLS-DA) model that allows for proving their relation, which in turn uncovers alternative influencing factors that remain hidden otherwise. We found two groups of variables that trace a strong relationship between metallomic and metabolomic parameters for disease development. The results confirmed that the redox active metals iron (Fe) and copper (Cu) together with fatty acids are the major influencing factors for the PD. Additionally, the metabolic waste product p-cresol sulfate and the trace element nickel (Ni) showed up as potentially important factors in PD. In summary, the data integration of different types of measurements emphasized the results of both stand-alone measurements providing a new comprehensive set of information and interactions, on PD disease, between different variables sources. Frontiers Media S.A. 2019-12-06 /pmc/articles/PMC6908950/ /pubmed/31866853 http://dx.doi.org/10.3389/fnagi.2019.00331 Text en Copyright © 2019 Lucio, Willkommen, Schroeter, Sigaroudi, Schmitt-Kopplin and Michalke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Lucio, Marianna Willkommen, Desiree Schroeter, Michael Sigaroudi, Ali Schmitt-Kopplin, Philippe Michalke, Bernhard Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title | Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title_full | Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title_fullStr | Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title_full_unstemmed | Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title_short | Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease |
title_sort | integrative metabolomic and metallomic analysis in a case–control cohort with parkinson’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908950/ https://www.ncbi.nlm.nih.gov/pubmed/31866853 http://dx.doi.org/10.3389/fnagi.2019.00331 |
work_keys_str_mv | AT luciomarianna integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease AT willkommendesiree integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease AT schroetermichael integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease AT sigaroudiali integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease AT schmittkopplinphilippe integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease AT michalkebernhard integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease |